A Phase I/Pilot Study of CPX-351 [Daunorubicin and Cytarabine Liposome for Injection (Vyxeos®)] for Children, Adolescents and Young Adults with Recurrent or Refractory Acute Leukemia

被引：0
|
作者：
Absalon, Michael J. [1 ]
Breese, Erin H. [1 ]
Lee, Lynn [1 ]
O'Brien, Maureen M. [1 ]
Phillips, Christine L. [1 ]
Burns, Karen [1 ]
Mizukawa, Benjamin [1 ]
An, Qi [2 ]
Mangino, Jennifer [1 ]
Kaplan, Joel [3 ]
Norris, Robin [1 ]
Perentesis, John Peter [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[2] Jazz Pharmaceut, Palo Alto, CA USA
[3] Levine Childrens Hosp, Carolinas Med Ctr, Charlotte, NC USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119618
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
336
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase I/pilot study of CPX-351 for children, adolescents and young adults with recurrent or refractory hematologic malignancies.
    Absalon, Michael
    O'Brien, Maureen Megan
    Phillips, Christine L.
    Burns, Karen Cristly
    Mangino, Jennifer
    Mizukawa, Benjamin
    Breese, Erin Haag
    Shah, Rachana
    Perentesis, John Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] IN VIVO RAT METABOLISM OF AN ACUTE MYELOID LEUKEMIA (AML) DRUG CPX-351 (CYTARABINE: DAUNORUBICIN) LIPOSOME INJECTION
    Kim-Kang, Heasook
    Yi, Yijun
    Wang, Peter L.
    Tardi, Paul
    Xie, Sherwin
    Mayer, Lawrence
    DRUG METABOLISM REVIEWS, 2015, 47 : 187 - 187
  • [3] Evaluation of CPX-351 (cytarabine:daunorubicin) liposome injection efficacy in acute lymphoblastic leukemia (ALL) xenograft models
    Mayer, Lawrence
    Carol, Hernan
    Morton, Christopher L.
    Harasym, Troy
    Smith, Malcolm A.
    Lock, Richard B.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [4] CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
    Lancet, Jeffrey E.
    Uy, Geoffrey L.
    Cortes, Jorge E.
    Newell, Laura F.
    Lin, Tara L.
    Ritchie, Ellen K.
    Stuart, Robert K.
    Strickland, Stephen A.
    Hogge, Donna
    Solomon, Scott R.
    Stone, Richard M.
    Bixby, Dale L.
    Kolitz, Jonathan E.
    Schiller, Gary J.
    Wieduwilt, Matthew J.
    Ryan, Daniel H.
    Hoering, Antje
    Banerjee, Kamalika
    Chiarella, Michael
    Louie, Arthur C.
    Medeiros, Bruno C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (26) : 2684 - +
  • [5] V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia
    Agresta, Laura
    O'Brien, Maureen M.
    Mizuno, Kana
    Norris, Robin
    Breese, Erin H.
    Phillips, Christine L.
    Burns, Karen
    Mizukawa, Benjamin
    Lee, Lynn
    Lane, Adam
    Lorsbach, Robert B.
    Ryan, Thomas D.
    Desai, Pankaj B.
    Vinks, Alexander A.
    Grimes, H. Leighton
    Perentesis, John P.
    Absalon, Michael J.
    BLOOD, 2019, 134
  • [6] A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia
    Shah, Bijal D.
    Rozario, Nicole
    Turba, Elyce P.
    Bello, Celeste
    Chavez, Julio C.
    Sokol, Lubomir
    Brayer, Jason
    Lancet, Jeffrey E.
    BLOOD, 2021, 138
  • [7] Leukemia Cell-Selective Uptake of Cytarabine and Daunorubicin in the Bone Marrow Compartment Mediated by CPX-351 Liposome Injection
    Lim, Wahseng
    Tardi, Paul
    Xie, Sherwin
    Fan, Mannie
    Huang, Ruby
    Harasym, Troy
    Mayer, Lawrence
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (03): : E29 - E29
  • [8] CPX-351 (cytarabine: daunorubicin liposome for injection) anti-leukemia activity is potentiated by Chk1 inhibition
    Vincelette, Nicole D.
    Karnitz, Larry M.
    Karp, Judith E.
    Smith, Douglas B.
    Hess, Allan D.
    Mayer, Lawrence D.
    Kaufmann, Scott H.
    CANCER RESEARCH, 2015, 75
  • [9] LEUKEMIA CELL-SELECTIVE UPTAKE OF CYTARABINE AND DAUNORUBICIN IN THE BONE MARROW COMPARTMENT MEDIATED BY CPX-351 LIPOSOME INJECTION
    Mayer, D.
    Lim, S.
    Tardi, G.
    Xie, X.
    Fan, M.
    Huang, X.
    Harasym, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 307 - 307
  • [10] Phase II Study of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality
    Borthakur, Gautam
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Daver, Naval
    Jabbour, Elias J.
    Kadia, Tapan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Pemmaraju, Naveen
    Konopleva, Marina
    Ohanian, Maro
    Wierda, William G.
    Jain, Nitin
    Xiao, Lian-Chun
    Mukherjee, Paromita
    Brandt, Mark
    Cortes, Jorge E.
    BLOOD, 2017, 130
12345